The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses

dc.contributor.authorDuran Aniotz, C.
dc.contributor.authorSegal, G.
dc.contributor.authorSalazar, L.
dc.contributor.authorPereda, C.
dc.contributor.authorFalcon, C.
dc.contributor.authorTempio, F.
dc.contributor.authorAguilera, R.
dc.contributor.authorNervi Nattero, Bruno
dc.date.accessioned2021-05-13T17:53:30Z
dc.date.available2021-05-13T17:53:30Z
dc.date.issued2013
dc.format.extent12 páginas
dc.fuente.origenConveris
dc.identifier.doi10.1007/s00262-012-1377-3
dc.identifier.eissn1432-0851
dc.identifier.issn0340-7004
dc.identifier.urihttps://doi.org/10.1007/s00262-012-1377-3
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/58489
dc.identifier.wosidWOS:000317626900013
dc.issue.numeroNo. 4
dc.language.isoen
dc.nota.accesoContenido parcial
dc.pagina.final772
dc.pagina.inicio761
dc.revistaCancer Immunology, Immunotherapyes_ES
dc.rightsacceso restringido
dc.subject.ods03 Good health and well-being
dc.subject.odspa03 Salud y bienestar
dc.titleThe immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responseses_ES
dc.typeartículo
dc.volumenVol. 62
sipa.codpersvinculados604
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1-Th17 and reduced Th3 cytokine responses.pdf
Size:
3.34 KB
Format:
Adobe Portable Document Format
Description: